Literature DB >> 15563659

Indeterminate colitis.

M Guindi1, R H Riddell.   

Abstract

Indeterminate colitis (IC) originally referred to those 10-15% of cases of inflammatory bowel disease (IBD) in which there was difficulty distinguishing between ulcerative colitis (UC) and Crohn's disease (CD) in the colectomy specimen. However, IC is increasingly used when a definitive diagnosis of UC or CD cannot be made at colonoscopy, in colonic biopsies or at colectomy. The diagnostic difficulties may explain the variably reported prevalence of IC. Clinically, most patients with IC evolve to a definite diagnosis of UC or CD on follow up. The role of ancillary tests in the distinction of UC from CD is reviewed. The low sensitivity of serological markers limits their usefulness. Other tests include upper endoscopy and magnetic resonance imaging. The definition of IC may not be a purely histological one derived from resected specimens, but rather a clinicopathological one. This review offers some personal observations and viewpoints, and proposes an approach to some of the relatively more esoteric combinations of findings.

Entities:  

Mesh:

Year:  2004        PMID: 15563659      PMCID: PMC1770507          DOI: 10.1136/jcp.2003.015214

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  91 in total

1.  Ischemic proctosigmoiditis.

Authors:  A E Bharucha; W J Tremaine; C D Johnson; K P Batts
Journal:  Am J Gastroenterol       Date:  1996-11       Impact factor: 10.864

2.  Diagnostic difficulty arising from rectal recovery in ulcerative colitis.

Authors:  T S Levine; M Tzardi; S Mitchell; C Sowter; A B Price
Journal:  J Clin Pathol       Date:  1996-04       Impact factor: 3.411

Review 3.  Non-steroidal anti-inflammatory drug-induced colitis.

Authors:  J L Faucheron; R Parc
Journal:  Int J Colorectal Dis       Date:  1996       Impact factor: 2.571

4.  Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists.

Authors:  B Moum; M H Vatn; A Ekbom; E Aadland; O Fausa; I Lygren; J Sauar; T Schulz; N Stray
Journal:  Scand J Gastroenterol       Date:  1996-04       Impact factor: 2.423

Review 5.  Diverticular disease and chronic idiopathic inflammatory bowel disease: associations and masquerades.

Authors:  N A Shepherd
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

6.  Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD).

Authors:  S Shivananda; J Lennard-Jones; R Logan; N Fear; A Price; L Carpenter; M van Blankenstein
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

7.  Ulcerative colitis complicated by gastroduodenal lesions.

Authors:  M Sasaki; K Okada; S Koyama; U Yoshioka; H Inoue; Y Fujiyama; T Bamba
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

8.  Diverticular disease-associated chronic colitis.

Authors:  L M Makapugay; P J Dean
Journal:  Am J Surg Pathol       Date:  1996-01       Impact factor: 6.394

9.  Histological discrimination of idiopathic inflammatory bowel disease from other types of colitis.

Authors:  N Le Berre; D Heresbach; M Kerbaol; S Caulet; J F Bretagne; J Chaperon; M Gosselin; M P Ramée
Journal:  J Clin Pathol       Date:  1995-08       Impact factor: 3.411

10.  Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study.

Authors:  C N Bernstein; F Shanahan; P A Anton; W M Weinstein
Journal:  Gastrointest Endosc       Date:  1995-09       Impact factor: 9.427

View more
  39 in total

1.  Anti-inflammatory efficiency of levobupivacaine in an experimental colitis model.

Authors:  Ugur Duman; Aysun Yilmazlar; Ersin Ozturk; Sibel Aker; Emre Sarandol; Tuncay Yilmazlar
Journal:  World J Gastroenterol       Date:  2010-05-28       Impact factor: 5.742

Review 2.  Terminology for the diagnosis of colitis.

Authors:  K Geboes; V Villanacci
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

3.  Molecular classification of Crohn's disease and ulcerative colitis patients using transcriptional profiles in peripheral blood mononuclear cells.

Authors:  Michael E Burczynski; Ron L Peterson; Natalie C Twine; Krystyna A Zuberek; Brendan J Brodeur; Lori Casciotti; Vasu Maganti; Padma S Reddy; Andrew Strahs; Fred Immermann; Walter Spinelli; Ulrich Schwertschlag; Anna M Slager; Monette M Cotreau; Andrew J Dorner
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

4.  Blockade of cytotoxic T-lymphocyte antigen-4 by ipilimumab results in dysregulation of gastrointestinal immunity in patients with advanced melanoma.

Authors:  David Berman; Susan M Parker; Jonathan Siegel; Scott D Chasalow; Jeffrey Weber; Susan Galbraith; Stephan R Targan; Hanlin L Wang
Journal:  Cancer Immun       Date:  2010-11-24

Review 5.  Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update.

Authors:  Cansel Turkay; Benan Kasapoglu
Journal:  Clinics (Sao Paulo)       Date:  2010-02       Impact factor: 2.365

Review 6.  Inflammatory bowel disease: an impaired barrier disease.

Authors:  Simon Jäger; Eduard F Stange; Jan Wehkamp
Journal:  Langenbecks Arch Surg       Date:  2012-11-18       Impact factor: 3.445

7.  Evaluation of diagnostic criteria for Crohn's disease in Japan.

Authors:  Takashi Hisabe; Fumihito Hirai; Toshiyuki Matsui; Mamoru Watanabe
Journal:  J Gastroenterol       Date:  2013-04-03       Impact factor: 7.527

Review 8.  Video capsule endoscopy in inflammatory bowel disease.

Authors:  Paul D Collins
Journal:  World J Gastrointest Endosc       Date:  2016-07-25

Review 9.  Role of capsule endoscopy in inflammatory bowel disease.

Authors:  Uri Kopylov; Ernest G Seidman
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

10.  Identification of novel serological biomarkers for inflammatory bowel disease using Escherichia coli proteome chip.

Authors:  Chien-Sheng Chen; Sean Sullivan; Troy Anderson; Aik Choon Tan; Philip J Alex; Steven R Brant; Carmen Cuffari; Theodore M Bayless; Monica V Talor; C Lynne Burek; Huan Wang; Richard Li; Lisa Wu Datta; Yuqiong Wu; Raimond L Winslow; Heng Zhu; Xuhang Li
Journal:  Mol Cell Proteomics       Date:  2009-04-07       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.